Mesoblast annual stock-based compensation
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Mesoblast Stock-Based Compensation Growth & History (MESO)
Mesoblast's stock-based compensation was $9.2M for fiscal 2025.
View full Mesoblast company overviewMesoblast annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | $9.2M | $3.3M | +56.73% |
| 2024 | 2024-06-30 | $5.9M | $2.2M | +60.60% |
| 2023 | 2023-06-30 | $3.7M | −$1.9M | −33.98% |
| 2022 | 2022-06-30 | $5.5M | −$7.0M | −55.75% |
| 2021 | 2021-06-30 | $12.5M | $5.0M | +66.31% |
| 2020 | 2020-06-30 | $7.5M | $3.2M | +72.21% |
| 2019 | 2019-06-30 | $4.4M | −$1.8M | −29.54% |
| 2018 | 2018-06-30 | $6.2M | $923,000 | +17.49% |
| 2017 | 2017-06-30 | $5.3M | $1.9M | +55.68% |
| 2016 | 2016-06-30 | $3.4M | — | — |
Mesoblast quarterly stock-based compensation
Q2.18
Q3.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q1.21
Q1.22
Q1.23
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q1 2023 | 2022-09-30 | $350,000 | −$726,000 | −67.47% |
| Q1 2022 | 2021-09-30 | $1.1M | −$3.8M | −77.96% |
| Q1 2021 | 2020-09-30 | $4.9M | $4.1M | +507.09% |
| Q2 2020 | 2019-12-31 | $1.6M | $435,000 | +36.01% |
| Q1 2020 | 2019-09-30 | $804,000 | −$14,000 | −1.71% |
| Q4 2019 | 2019-06-30 | $1.2M | — | — |
| Q3 2019 | 2019-03-31 | $1.2M | −$69,000 | −5.48% |
| Q2 2019 | 2018-12-31 | $1.2M | −$932,333 | −43.56% |
| Q1 2019 | 2018-09-30 | $818,000 | — | — |
| Q3 2018 | 2018-03-31 | $1.3M | — | — |
| Q2 2018 | 2017-12-31 | $2.1M | — | — |
Mesoblast stock-based compensation trends
Over the last five fiscal years, Mesoblast's stock-based compensation increased from $7.5M to $9.2M, a change of $1.7M. The latest reported quarter, Q1 2023, shows $350,000.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Mesoblast source filings ↗